Related Experiment Video
Updated: Aug 7, 2026
12:22
The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
Current clinical trials in renal cell carcinoma
Mitchell H Sokoloff1, Siamak Daneshmand, Christopher W Ryan
1Department of Surgery, Section of Urologic Oncology, Division of Urology and Renal Transplantation, Portland, OR 97239-3098, USA. guonc@ohsu.edu
Urologic Oncology
|July 16, 2005
Summary
Urologists are crucial in advancing kidney cancer treatment through clinical trials, especially in the adjuvant setting after nephrectomy. Future research will expand their role as new therapies emerge for renal cell carcinoma.
Area of Science:
- Urology
- Oncology
- Nephrology
Background:
- Renal cell carcinoma (kidney cancer) treatment is predominantly surgical.
- Urologists play a significant role in designing and conducting clinical trials for kidney cancer patients.
- Current urologic clinical trial efforts focus on the adjuvant setting for patients post-nephrectomy with high recurrence risk.
Purpose of the Study:
- To review key clinical trials for patients with kidney cancer.
- To highlight the evolving role of urologists in renal cell carcinoma research.
Main Methods:
- This is a review article.
- It synthesizes information from current clinical trials in renal cell carcinoma.
- Focuses on trials relevant to urologic surgical practice.
Main Results:
- Urologists are actively involved in kidney cancer clinical trials.
- The focus is on adjuvant therapy post-nephrectomy for high-risk patients.
- The involvement of urologists is expected to grow with new therapeutic agents.
Conclusions:
- Surgical management remains central to renal cell carcinoma treatment.
- Urologists are integral to advancing kidney cancer care through clinical trials.
- The scope of urologic involvement in clinical trials will expand as therapies evolve.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...